Mirada’s AI Software Cleared by FDA

July 20, 2018

The FDA granted 510(k) clearance for imaging software developer Mirada’s artificial intelligence DLC Expert software, approving it to be used for planning radiation oncology treatment.

The software helps users spot tumors and important structures on patient CT scans, reducing the time it typically takes to perform an analysis.

The software is part of Mirada’s Workflow Box 2.0 Zero-Click platform, which provides data routing and support for custom applications.

View today's stories